EMA Poised To Decide On Fate Of Lilly’s Kisunla And PharmaMar’s Aplidin In EU

People standing out from the crowd. Human resource, Talent management, Recruitment employee, Successful business team leader. red figure, leadership concept. Leader standing out from the crown
EMA’s rejection of Kisunla was out of step with the decisions of other regulatory agencies (Shutterstock)

More from EU CHMP

More from Product Reviews